Draximage agent looks for bone infection in US trial
This article was originally published in Clinica
Executive Summary
Draximage is to start in the US a phase II clinical trial of its radiopharmaceutical molecular imaging agent for detecting, and determining the location of, difficult-to-diagnose infection in the body.